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ABSTRACT   A 71-year-old woman diagnosed with mycosis fungoides with multiple 
erythematous plaques and follicular papules on the scalp, trunk, and thigh was referred to our 
institution. Folliculotropic mycosis fungoides was histologically diagnosed, and the erythematous 
papules and plaques regressed temporarily after total-skin electron beam therapy. The patient 
then developed tumors and erythroderma. The area of painful erosion spread, and her condition 
rapidly worsened. The patient died 3 years and 4 months after the first examination due to 
multiple organ failure caused by sepsis. The cause of rapid evolution into erythroderma remains 
elusive and requires further investigation in similar cases.
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〈Case Report〉
atypical T lymphocytes are present, occasionally 
with epidermotropism. MF generally progress 
slowly through several stages. However, the 
prognosis of FMF is significantly worse than 
the classic type of MF１）, with reported disease-
free survival rates of 68% at 5 years and 26% at 
10 years２）. Herein, we report an unusual case of 
FMF that evolved into fatal, tumor-stage MF and 
erythroderma with multiple ulcerations.
CASE REPORT
   A 71-year-old woman diagnosed with MF was 
INTRODUCTION
   Mycosis fungoides (MF) is the most common 
form of primary cutaneous T cell lymphoma, and 
is clinically characterized by skin patches that 
subsequently evolve into plaques and tumors１）. 
Histologically, MF is defined by the proliferation 
of small- to medium-sized T lymphocytes with 
cerebriform nuclei１）. Folliculotropic MF (FMF) is 
an uncommon variant of MF that is characterized by 
acneiform and follicular papules and plaques２－６）. 
The grouped follicular papules are often associated 
with alopecia. In FMF, follicular infiltrates of 
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was evident, but scattered CD8+ cells were also 
detected. Additionally, these infiltrated cells 
included cells positive for cytotoxic marker T-cell 
intracellular antigen (TIA)-1 and granzyme B (GrB). 
Programmed death-1 receptor was barely detectable 
in infiltrated lymphocytes. T-cell receptor Cβ1 
gene rearrangement was detected in the skin biopsy 
specimen. Serological tests were negative for human 
T-cell leukemia virus 1 (HTLV-1). The patient was 
diagnosed with FMF, stage IB (T2b, N0, M0, B0).
   The erythematous papules and plaques regressed 
temporarily after total-skin electron beam therapy 
(TSEBT) (cumulative dose, 16 Gy). However, 
10 months later, new plaques developed, and so 
additional TSEBT (12 Gy), and localized electron 
beam therapy (LEBT) (10 Gy) were conducted. 
Ten months later, 4  months of combination 
referred to our institution due to a 3-year history of 
intensely pruritic skin lesions that were resistant to 
the treatments of psoralen phototherapy, interferon
γ, and etoposide. Physical examination revealed 
multiple erythematous plaques and follicular 
papules on the scalp, trunk, and thigh (Fig. 1a, 
1b). The patient had no systemic symptoms or 
lymphadenopathy. A biopsy taken from a follicular 
papule on her scalp showed epidermotropism 
with Pautrier’s microabscess in the epidermis and 
diffuse infiltration of lymphocytes and eosinophils 
in the dermis (Fig. 1c). An intensive folliculotropic 
lymphoid infiltration was detected in the dermis 
(Fig. 1d). Mucin deposition within the follicular 
epithelium was present. The lymphocytes were 
positive for CD3, but negative for CD20, CD56, 
and CD79a. The predominance of CD4+ cells 
Fig. 1. Clinical and histopathological features at the initial presentation
(a) Brownish-colored erythematous plaques on the back. (b) Multiple follicular papules on the thigh. (c) Abundant 
infiltration of lymphoid cells and eosinophils in the dermis with an intraepidermal vesicle and Pautrier’s microabscess 
(hematoxylin-eosin [HE], original magnification ×100). (d) Intensive lymphoid infiltration in the hair follicle (HE, ×
200).
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chemotherapy was administered (oral etoposide 25 
mg/day on days 1-3, q7, with oral sobuzoxane 400 
mg/day on day 1, q7). However, 5 months later, new 
nodules, erosions, and ulcers developed on the trunk 
and extremities (Fig. 2a). Although additional LEBT 
(20 Gy) was performed, the erythematous skin 
lesions evolved into erythroderma with multiple 
ulcerative lesions (Fig. 2b). A skin biopsy from the 
abdomen showed a dense lymphoid infiltrate in 
the superficial dermis with epidermotropism (Fig. 
2c). The CD4+ neoplastic cells still outnumbered 
the CD8+ cells (Fig. 2d). TIA-1- and GrB-positive 
cells were also seen (Fig. 2e). The area of painful 
erosion spread, and her condition rapidly worsened. 
Giant cells associated with herpes simplex virus 
or varicella zoster virus were not detected, and 
polymerase chain reaction studies of cutaneous 
ulcerations were negative for varicella zoster virus 
and herpes simplex virus. Cytomegalovirus (CMV) 
was not detected by immunohistochemical staining. 
It was difficult to resume chemotherapy because of 
poor general condition, therefore only continuous 
symptomatic treatment could be provided. During 
the course, CMV antigenemia was detected using 
the C7HRP method and was treated with ganciclovir. 
However, skin-related symptoms persisted without 
obvious improvement. Despite Sezary cells not 
being detected in the peripheral blood and there 
being no evidence of organ infiltration upon imaging 
diagnostic tests, blood soluble interleukin-2 receptor 
(sIL-2R) levels gradually increased throughout the 
clinical course, with the final value being 10, 100 U 
/ mL. The patient died at 3 years and 4 months after 
the first examination due to multiple organ failure 
caused by sepsis.
DISCUSSION
   The most common findings in FMF are grouped 
follicular papules and patch or plaque lesions, while 
erythroderma is observed in only 6-18% of patients 
Fig. 2. Clinical, histopathological, and immunohistopathological features in the advanced stage
(a) Nodules and erythematous plaques on the arm. (b) Painful ulcerations and erosions on the buttocks. (c) Dense 
lymphoid infiltration in the superficial dermis with epidermotropism (HE, ×400) (d) Immunostaining for CD4 (x100). 
(e) Immunostaining for T-cell intracellular antigen-1 (TIA-1, x400).
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with FMF３－５）. Although TSEBT is considered an 
effective therapy for FMF３）, a recent review of 24 
patients with FMF treated with TSEBT showed 
that only 33.3% and 20.5% had a complete and 
partial response, respectively６）. The skin lesions in 
the current case recurred after a clinical remission 
of only 5-6 months after TSEBT, and evolved 
into erythroderma with multiple ulcerations. In a 
previously reported case of MF presenting with 
multiple ulcerations due to disseminated cutaneous 
CMV infection, the TSEBT was thought to be a 
possible inciting factor that reactivated a latent 
CMV infection７）. Such viral infections were 
not demonstrated in the current case. Abundant 
eosinophilic infiltration in skin lesions might be 
associated with resistance to TSEBT８）. Correlation 
analysis between GrB/TIA-1 expression in first 
diagnostic biopsies from patches or plaques from 
40 patients with T2N0M0-stage MF and clinical 
follow-up data did not reveal differences in clinical 
behavior and survival９）. It is unlikely that these 
lesions developed as acute complications of TSEBT, 
as they appeared 10 months after the completion 
of TSEBT and LEBT10，11）. The cause of the rapid 
evolution into erythroderma remains elusive and 
requires further investigation in similar cases of 
FMF.
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